Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Novartis
Moodys
Healthtrust
Argus Health
Daiichi Sankyo
Cerilliant
Covington
Merck
Fuji

Generated: October 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022198

« Back to Dashboard
NDA 022198 describes SANCUSO, which is a drug marketed by Kyowa Kirin and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the SANCUSO profile page.

The generic ingredient in SANCUSO is granisetron. There are twenty-six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the granisetron profile page.

Summary for NDA: 022198

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 022198

Suppliers and Packaging for NDA: 022198

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SANCUSO
granisetron
FILM, EXTENDED RELEASE;TRANSDERMAL 022198 NDA Kyowa Kirin, Inc. 42747-726 42747-726-01 1 POUCH in 1 CARTON (42747-726-01) > 1 PATCH in 1 POUCH > 168 h in 1 PATCH
SANCUSO
granisetron
FILM, EXTENDED RELEASE;TRANSDERMAL 022198 NDA Physicians Total Care, Inc. 54868-5985 54868-5985-0 1 POUCH in 1 CARTON (54868-5985-0) > 1 PATCH in 1 POUCH > 168 h in 1 PATCH

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength3.1MG/24HR
Approval Date:Sep 12, 2008TE:RLD:Yes
Patent:► SubscribePatent Expiration:Jan 22, 2025Product Flag?YSubstance Flag?Delist Request?
Patented Use:USE OF GRANISETRON TRANSDERMAL SYSTEM TO TREAT/PREVENT CHEMOTHERAPY INDUCED NAUSEA AND VOMITING


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
Covington
Fuji
Baxter
Queensland Health
Teva
Citi
Dow
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot